TABLE 1.
Minimum inhibition concentration (MIC) of the antimicrobial peptides and antibiotics against three different Pseudomonas aeruginosa strains.
| μg mL–1(μM) | PAO1a | PA 19660b | PA-OSc | |||
| NaCl | ||||||
| 0 mM | 150 mM | 0 mM | 150 mM | 0 mM | 150 mM | |
| LL-37 | 50(11.12) | 100(22.24) | 50(11.12) | 100(22.24) | 50(11.12) | 100(22.24) |
| FK13 | 100(28.14) | 200(116.28) | 200(116.28) | >200(>116.28) | 200(116.28) | >200(>116.28) |
| FK16 | 100(48.85) | 200(97.70) | 100(48.85) | 200(97.70) | 100(48.85) | 200(97.70) |
| Gentamicin | 4(8.37) | 8(16.74) | 4(8.37) | 8(16.74) | 4(8.37) | 8(16.74) |
| Amikacin | 1(1.71) | 2(3.42) | 1(1.71) | 2(3.42) | 1(1.71) | 2(3.42) |
| Vancomycin | >256(>176) | >256(>176) | >256(>176) | >256(>176) | >256(>176) | >256(>176) |
aOpportunistic pathogen that causes invasive infection. bCytotoxic strain from ATCC. cClinical isolate from the ocular surface of patient.